πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 164 of 200 Β· A–Z by INN

  1. sarecycline

    NMPA: clinical trials

  2. sarecycline hydrochloride

    SEYSARA Almirall, S.A.

    ORAL FDA: approved

  3. sargramostim

    IMREPLYS

    FDA: approved Β· EMA: approved Β· PMDA: approved

    L03AA09
  4. sarilumab

    KEVZARA

    INJECTION FDA: approved Β· EMA: approved Β· PMDA: approved

    L04AC14
  5. sars-cov-

    NMPA: clinical trials

  6. sasanlimab

    ZUMRAD

    EMA: application withdrawn

    L01FF
  7. satavaptan

    AQUILDA

    EMA: application withdrawn

  8. satralizumab

    ENSPRYNG

    INJECTION FDA: approved Β· EMA: approved Β· PMDA: approved Β· NMPA: clinical trials

    L04AC
  9. satraplatin

    ORPLATNA

    EMA: application withdrawn

  10. saxagliptin

    ONGLYZA AstraZeneca

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    A10BD21
  11. saxagliptin + dapagliflozin

    QTERN 5/10 AstraZeneca

    TGA: approved

  12. saxagliptin + metformin

    KOMBIGLYZE XR 2.5/1000 AstraZeneca

    TGA: approved

  13. saxagliptin hydrochloride

    SAXAGLIPTIN Amneal Pharma Europe Ltd

    ORAL FDA: approved

  14. sc0191

    NMPA: clinical trials

  15. sc0191 + 5-fu/lv

    NMPA: clinical trials

  16. scopolamine

    SCOPOLAMINE Amneal Pharma Europe Ltd

    TRANSDERMAL FDA: approved

  17. sebelipase alfa

    KANUMA

    INJECTION FDA: approved Β· EMA: approved Β· PMDA: approved

    A16
  18. sebetralstat

    EKTERLY Kalvista Pharmaceuticals (Ireland) Limited

    ORAL FDA: approved Β· EMA: approved

    B06AC08
  19. secnidazole

    SOLOSEC Evofem Biosciences

    ORAL FDA: approved

  20. secobarbital sodium

    SECONAL SODIUM

    RECTAL FDA: approved

  21. secretin

    SECRETIN-FERRING

    INJECTION FDA: approved

  22. secretin synthetic human

    CHIRHOSTIM

    INTRAVENOUS FDA: approved

  23. secretin synthetic porcine

    SECREFLO

    INTRAVENOUS FDA: approved

  24. secukinumab

    COSENTYX Novartis Pharmaceuticals

    INJECTION FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved Β· NMPA: clinical trials

    L04AC10

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources